These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1278230)

  • 1. Inhibition and potentiation of apomorphine-induced hypermotility in rats by neuroleptics.
    Lassen JB
    Eur J Pharmacol; 1976 Apr; 36(2):385-93. PubMed ID: 1278230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):418-29. PubMed ID: 576565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 4,alpha-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chloropromazine, haloperidol, clozapine and thioridazine.
    Buus Lassen J
    Psychopharmacologia; 1975 Jul; 43(1):25-9. PubMed ID: 51502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
    Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of neuroleptics, midantan and DOPA on apomorphine sterotypy in rats].
    Kalinin VV
    Farmakol Toksikol; 1977; 40(1):16-9. PubMed ID: 558110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD-potentiated apomorphine hypermotility: a model for differentiating antipsychotic drugs.
    Morgenstern R; Fink H; Oelssner W
    Pharmacol Biochem Behav; 1983 Jan; 18(1):13-7. PubMed ID: 6681904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
    Lipska BK; Weinberger DR
    Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Jan; 35(1):161-8. PubMed ID: 1253817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of apomorphine on motility in rats.
    Maj J; Grabowska M; Gajda L
    Eur J Pharmacol; 1972 Feb; 17(2):208-14. PubMed ID: 5026397
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of apomorphine-induced aggression by morphine or neuroleptics: differential alteration by antimuscarinics and naloxone.
    Gianutsos G; Lal H
    Pharmacol Biochem Behav; 1976 Jun; 4(6):639-42. PubMed ID: 988593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
    Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of apomorphine's discriminative stimulus properties: relation to neuroleptic activity in neuropharmacological and biochemical assays.
    Colpaert FC; Leysen JE; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Dec; 5(6):671-9. PubMed ID: 1035804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation.
    Megens AA; Hendrickx HM; Lavreysen H; Langlois X
    J Pharmacol Exp Ther; 2013 Dec; 347(3):681-96. PubMed ID: 24071734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
    Fredriksson A; Eriksson P; Archer T
    J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
    Vonvoigtlander PF; Losey EG; Triezenberg HJ
    J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the supersensitivity of dopamine receptors, induced by neuroleptics.
    Christensen AV; Fjalland B; Nielsen IM
    Psychopharmacology (Berl); 1976 Jul; 48(1):1-6. PubMed ID: 9655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
    Guyenet PG; Javory AF; Beaujouan JC; Rossier BJ; Glowinski J
    Brain Res; 1975 Feb; 84(2):227-44. PubMed ID: 234276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.